MOLPATH.TRISOMY
Laboratory58 LOINC codes in this class
42713-8AML/MDS gene CEP 8 trisomy [Presence] in Blood or Tissue by Molecular genetics methodL35123-9Chromosome 14 uniparental disomy [Presence] in Blood or Tissue by CytogeneticsL75394-7Chromosome uniparental disomy [Identifier] in Amniotic fluid or Chorionic villus sample by Molecular genetics method NarrativeL36907-4Chromosome 8 trisomy [Percentile] by CytogeneticsL34503-3Chromosome 15 uniparental disomy [Presence] in Blood or Tissue by CytogeneticsL21770-3Chromosome 12 trisomy [Presence] in Blood or Tissue by CytogeneticsL36917-3Chromosome uniparental disomy [Identifier] in Blood or Tissue by Molecular genetics method NarrativeL73970-6Fetal Trisomy 21 risk [Likelihood] based on Plasma cell-free DNA by Dosage of chromosome-specific cfDNAL73969-8Fetal Trisomy 13 risk [Likelihood] based on Plasma cell-free DNA by Dosage of chromosome-specific cfDNAL73968-0Fetal Trisomy 18 risk [Likelihood] based on Plasma cell-free DNA by Dosage of chromosome-specific cfDNAL73966-4Fetal Trisomy 21 risk [Interpretation] based on Plasma cell-free DNA by Dosage of chromosome-specific cfDNA QualitativeL73825-2Fetal Trisomy 18 risk [Interpretation] based on Plasma cell-free DNA by Dosage of chromosome-specific cfDNA QualitativeL73824-5Fetal Trisomy 13 risk [Interpretation] based on Plasma cell-free DNA by Dosage of chromosome-specific cfDNA QualitativeL75546-2Fetal Trisomy 13 prior risk [Likelihood] Based on maternal ageL75975-3Fetal Chromosome 13+18+21 trisomy [Presence] based on Plasma cell-free DNA by Dosage of chromosome-specific cfDNAL75980-3Fetal Chromosome 13+18+21+X+Y aneuploidy [Presence] based on Plasma cell-free DNA by Dosage of chromosome-specific cfDNAL21771-1Chromosome 21 trisomy [Presence] in Blood or Tissue by CytogeneticsL75979-5Fetal Chromosome 13 trisomy [Interpretation] based on Plasma cell-free DNA by Dosage of chromosome-specific cfDNA QualitativeL75978-7Fetal Chromosome 18 trisomy [Interpretation] based on Plasma cell-free DNA by Dosage of chromosome-specific cfDNA QualitativeL75976-1Fetal Chromosome 21 trisomy [Interpretation] based on Plasma cell-free DNA by Dosage of chromosome-specific cfDNA QualitativeL75981-1Fetal Chromosome 13 trisomy [Presence] based on Plasma cell-free DNA by Dosage of chromosome-specific cfDNAL75982-9Fetal Chromosome 18 trisomy [Presence] based on Plasma cell-free DNA by Dosage of chromosome-specific cfDNAL75983-7Fetal Chromosome 21 trisomy [Presence] based on Plasma cell-free DNA by Dosage of chromosome-specific cfDNAL111735-7Chromosomal aneuploidy likelihood analysis in Plasma cell-free DNA by NIPSL21772-9Chromosome 7 trisomy [Presence] in Blood or Tissue by CytogeneticsL21773-7Chromosome 8 trisomy [Presence] in Blood or Tissue by CytogeneticsL21774-5Chromosome 9 trisomy [Presence] in Blood or Tissue by CytogeneticsL34496-0Chromosome 7 uniparental disomy [Presence] in Blood or Tissue by CytogeneticsL35292-2Chromosome 11 uniparental disomy [Presence] in Blood or Tissue by CytogeneticsL43306-0Chromosome 21 trisomy [Percentile] by CytogeneticsL75548-8Fetal Trisomy 13 risk [Likelihood] based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNAL75550-4Fetal Trisomy 13 prior risk [Likelihood] Based on maternal age NarrativeL75551-2Fetal Trisomy 13 risk [Likelihood] based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA NarrativeL75552-0Fetal Trisomy 13 risk [Interpretation] based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA QualitativeL75553-8Comment on fetal Trisomy 13 risk [Text] in Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA NarrativeL75554-6Fetal Trisomy 18 prior risk [Likelihood] Based on maternal ageL75555-3Fetal Trisomy 18 risk [Likelihood] based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNAL75556-1Fetal Trisomy 18 prior risk [Likelihood] Based on maternal age NarrativeL75557-9Fetal Trisomy 18 risk [Likelihood] based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA NarrativeL75558-7Fetal Trisomy 18 risk [Interpretation] based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA QualitativeL75559-5Comment on fetal Trisomy 18 risk [Text] in Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA NarrativeL75560-3Fetal Trisomy 21 prior risk [Likelihood] Based on maternal ageL75561-1Fetal Trisomy 21 risk [Likelihood] based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNAL75562-9Fetal Trisomy 21 prior risk [Likelihood] Based on maternal age NarrativeL75563-7Fetal Trisomy 21 risk [Likelihood] based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA NarrativeL75564-5Fetal Trisomy 21 risk [Interpretation] based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA QualitativeL75565-2Comment on fetal Trisomy 21 risk [Text] in Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA NarrativeL75572-8Fetal Triploidy risk [Interpretation] based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA QualitativeL75573-6Comment on fetal Triploidy risk [Interpretation] based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA NarrativeL77011-5Fetal Chromosome 21 trisomy [Presence] based on Plasma cell-free DNA by SequencingL77012-3Fetal Chromosome 18 trisomy [Presence] based on Plasma cell-free DNA by SequencingL77013-1Fetal Chromosome 13 trisomy [Presence] based on Plasma cell-free DNA by SequencingL77014-9Fetal Trisomy 21 risk [Interpretation] based on Plasma cell-free DNA by Sequencing QualitativeL77015-6Fetal Trisomy 18 risk [Interpretation] based on Plasma cell-free DNA by Sequencing QualitativeL77619-5Fetal chromosome 13+18+21+Y aneuploidy [Presence] based on dosage of chromosome-specific cell-free DNA from Maternal plasmaL78237-5Chromosome 8 copy number/nucleus in Blood or Tissue by FISHL78238-3Chromosome 3 copy number/nucleus in Blood or Tissue by FISHL84913-3Cells.chromosome 12 trisomy/Cells counted in Blood or Tissue by FISHL